Seeing Is Believing
Healthcare - Sector
Sigilon Therapeutics's activity chart (see below) currently has 9 price targets and 13 ratings on display.
Analysts average stock forecasts to be materialized ratio is 81.67% with an average time for these price targets to be met of 174.3 days.
Most recent stock forecast was given by WHITNEY IJEM from CANACCORD on 05-Jul-2023. First documented stock forecast 19-Jul-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Jan-2023
$30
$7.53 (33.51%)
$6
3 years 3 months 4 days ago
(05-Jul-2023)
1/2 (50%)
$8.45 (39.21%)
127
Hold Since 26-May-2023
$21
$-1.47 (-6.54%)
$7
3 years 3 months 6 days ago
(03-Jul-2023)
2/2 (100%)
$-1.5 (-6.67%)
29
Buy Since 29-Oct-2021
$14
3 years 3 months 9 days ago
(30-Jun-2023)
2/2 (100%)
$-50.35 (-78.24%)
173
Buy Since 19-Jul-2021
$7
$-15.47 (-68.85%)
$7
4 years 9 months 11 days ago
(28-Dec-2021)
3/3 (100%)
$-28.1 (-80.06%)
225
Buy Since 11-Aug-2021
$7
4 years 10 months 7 days ago
(02-Dec-2021)
2/2 (100%)
$-33.82 (-82.85%)
274
What is SGTX (Sigilon Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on SGTX (Sigilon Therapeutics)?
Which analyst has the most public recommendations on SGTX (Sigilon Therapeutics)?
Which analyst is the currently most bullish on SGTX (Sigilon Therapeutics)?
Which analyst is the currently most reserved on SGTX (Sigilon Therapeutics)?